News
BioNTech reports rapid progress on COVID-19 vaccine program to address global public health threat
BioNTech SE provides further details on the Company’s R&D effort, “Project Lightspeed”, to develop a potential vaccine to induce immunity and prevent COVID-19 infection in response to the growing global health threat posed by the disease. BioNTech’s product candidate,...
News
Nurix raises $120m financing to advance its protein modulation pipeline
San Francisco based-Nurix has closed its funding round with a total of $120m. The financing was led by Foresite Capital and supported by new investors Bain Capital Life Sciences, Boxer Capital, EcoR1 Capital, Redmile Group and Wellington Management Company....
News
Mallinckrodt Pharmaceuticals explores iNO as potential Covid-19 therapy
Mallinckrodt has started exploring inhaled nitric oxide (iNO) as a potential supportive measure for COVID-19 patients with pulmonary complications.
The company partnered with the US Food and Drug Administration (FDA), the National Institutes of Health (NIH) and the Biomedical Advanced...
News
LANXESS India donates disinfectants to Thane Municipal Corporation
To help fight the current COVID-19 pandemic in India, specialty chemicals company LANXESS India has donated its highly effective Rely+Onâ„¢ Virkonâ„¢ disinfectant to Thane Municipal Corporation (TMC) to reduce the cross contamination of COVID-19 in civic hospitals and other...
News
Bormioli Pharma Speeds Up on Innovation With H-FARM
Fast prototyping and an approach to innovation focused on customer needs are at the heart of the innovation path undertaken by Bormioli Pharma alongside H-FARM. The goal is to simplify the business model and the whole process of creating...
News
WuXi Biologics Completes Weather-Tight Seal of its Biologics Manufacturing Facility in Ireland
WuXi Biologics , a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced that it has completed the weather-tight seal of its biologics drug substance manufacturing facility on the Dundalk Campus...
News
Invitae to Acquire YouScript and Genelex to Make it Easier to Use Pharmacogenetic Information at the Point of Care
Invitae Corporation , a leading medical genetics company, announced it has entered into definitive agreements to acquire YouScript, a privately held clinical decision support and analytics platform, and Genelex, a privately held pharmacogenetic teasting company, to bring best-in-class pharmacogenetic...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read